Floatz logo

Fluorouracilum

Liver And Intrahepatic Bile Duct Neoplasm

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the Liver And Intrahepatic Bile Duct Neoplasm cohort.

Asset / SponsorPhaseRating
Irinotecan
Tehran University of Medical Sciences
Phase 4BBB
Chlorhexidine
Changhua Christian Hospital
Phase 4BB
Albumin Aggregated
Sirtex Medical
Phase 4BB
Talaporfin
Light Sciences Oncology
Phase 3BB
Xaliplatin
Shanghai Zhongshan Hospital
Phase 4BB

View all 49 →

Same molecule, other indications

Fluorouracilum is also rated in:

exocrine pancreatic carcinomaActive
BBB
Indicative · Phase 2/3
78 / 100
View asset →
colon adenocarcinomaActive
BBB
Indicative · Phase 3
77 / 100
View asset →
rectal cancerActive
BBB
Indicative · Phase 3
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →